Guest writer Joanna Buoniconti says that new treatments have granted her many things she's grateful for, including the ...

Spinraza, which is used to treat spinal muscular atrophy, can cause side effects. Learn about its mild and serious side effects and how to manage them.

BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.

Biogen announced topline data from the Phase 2/3 DEVOTE study showing a higher dose of nusinersen significantly improves motor function in treatment-naïve infants with spinal muscular atrophy ...

If approved, the device could shift Spinraza administration from specialized visits requiring anesthesia and radiation exposure to an outpatient setting. The company said that implantation procedures ...

Biogen's latest SMA research! Interim data from the RESPOND study reveals promising outcomes with SPINRAZA treatment. Learn about reduced NfL levels and the impact on infants and children with ...

Spinraza is used to treat spinal muscular atrophy (SMA). Find out what the recommended dosage is, how to take the drug, and more.

A procedure called interlaminar fenestration was used to gain access to the spinal canal for Spinraza injections after scoliosis surgery.

In 2016, Spinraza became the first FDA-approved treatment for spinal muscular atrophy. Researchers have found a way the therapeutic effects of Spinraza may be improved. They discovered that ...

He was ineligible for the drug Spinraza because of rules from regulator Nice, which required him to have walked in the previous 12 months.

GlobalData expects Biogen’s Spinraza to continue maintaining a strong position in the SMA market primarily due to the fact that it will be first to market, as well as patient and physician familiarity ...

She began taking Spinraza a year ago, and each infusion means a trip to the hospital radiology department to help physicians access her spinal canal. But even though the procedure can be painful, “for ...